Friday, January 30, 2009

Nice Article on the Zyprexa Debacle

›
In the course of this past month I have been blogging about Eli Lilly and Zyprexa (olanzapine) and how the company marketing managed to make...
2 comments:
Tuesday, January 27, 2009

Compassion or Conflict of Interest? New Medicare Cancer Coverage Rules

›
Check out these sources on the recent Medicare rules change for coverage of cancer drugs: http://online.wsj.com/article/SB123302745342318667...
Monday, January 26, 2009

The Outsourcing of Drug Supply: Market Failure

›
I would have thought that this article by Gardiner Harris would have stirred up more of a fuss: http://www.nytimes.com/2009/01/20/health/pol...
1 comment:

Is Device Industry Shaping Up?

›
According to Barry Meier in the New York Times -- http://www.nytimes.com/2009/01/24/business/24device.html?ref=health --the medical device i...

Protecting Prescription Privacy from Industry Marketing

›
So much recent legislative attention has been focused on sunshine biils, requiring disclosure of physician payments from the drug companies,...
1 comment:

Change in Washington and Elsewhere--Latest News

›
Several news items in the last 24 hours' worth of e-mail. Our friends at Integrity in Science Watch report on the reintroduction by Sens...
Friday, January 23, 2009

Lilly Fine for Zyprexa Off Label Marketing: $1.4B

›
When it came to fines paid for illegal marketing practices, the big drug companies had for some time been stuck in the mere hundreds of mill...
3 comments: